BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1380109)

  • 1. A simplified method for the preparation of tetanus toxin binding fragment for neurobiology.
    Fishman PS; Farrand DA; Halpern JL; Latham WC
    J Neurosci Methods; 1992 May; 42(3):229-36. PubMed ID: 1380109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization does not interfere with uptake and transport by motor neurons of the binding fragment of tetanus toxin.
    Fishman PS; Matthews CC; Parks DA; Box M; Fairweather NF
    J Neurosci Res; 2006 Jun; 83(8):1540-3. PubMed ID: 16557581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
    Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
    J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
    Matsuda M; Kamei M; Sugimoto N; Ma Y; Hashizume S
    Eur J Epidemiol; 1992 Jan; 8(1):1-8. PubMed ID: 1572415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor.
    Herreros J; Lalli G; Schiavo G
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):199-204. PubMed ID: 10727419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
    Simpson LL
    J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment.
    Robinson JP; Chen HC; Hash JH; Puett D
    Mol Cell Biochem; 1978 Oct; 21(1):23-31. PubMed ID: 104144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tetanus toxin fragment C binding to ganglioside G(T1b) by monoclonal antibodies recognizing different epitopes.
    Fitzsimmons SP; Clark KC; Wilkerson R; Shapiro MA
    Vaccine; 2000 Aug; 19(1):114-21. PubMed ID: 10924793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutants of tetanus toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties.
    Sinha K; Box M; Lalli G; Schiavo G; Schneider H; Groves M; Siligardi G; Fairweather N
    Mol Microbiol; 2000 Sep; 37(5):1041-51. PubMed ID: 10972823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies.
    Goretzki K; Habermann E
    Med Microbiol Immunol; 1985; 174(3):139-50. PubMed ID: 3897815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin.
    Matsuda M; Yoneda M
    Infect Immun; 1975 Nov; 12(5):1147-53. PubMed ID: 1104484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde transneuronal transfer of the C-fragment of tetanus toxin.
    Fishman PS; Carrigan DR
    Brain Res; 1987 Mar; 406(1-2):275-9. PubMed ID: 3567626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A candidate carrier protein for beta-human chorionic gonadotropin: 54,000-molecular-weight fragment of tetanus toxin.
    Covey DC; Moore DE; Chang CC; Laurence KA
    Am J Reprod Immunol Microbiol; 1985 Jun; 8(2):43-7. PubMed ID: 2411156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems.
    Bizzini B; Stoeckel K; Schwab M
    J Neurochem; 1977 Mar; 28(3):529-42. PubMed ID: 67185
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
    Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
    Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level Expression of Tetanus Toxin Fragment C in Escherichia coli.
    Aghaiypour K; Teymourpour R
    Arch Razi Inst; 2018 Dec; 73(1):27-38. PubMed ID: 30256036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tetanus toxin subfragments in vitro and characterization of epitopes.
    Andersen-Beckh B; Binz T; Kurazono H; Mayer T; Eisel U; Niemann H
    Infect Immun; 1989 Nov; 57(11):3498-505. PubMed ID: 2478475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrograde transneuronal transport properties of fragment C of tetanus toxin.
    Manning KA; Erichsen JT; Evinger C
    Neuroscience; 1990; 34(1):251-63. PubMed ID: 1691466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment C of tetanus toxin: new insights into its neuronal signaling pathway.
    Calvo AC; Oliván S; Manzano R; Zaragoza P; Aguilera J; Osta R
    Int J Mol Sci; 2012; 13(6):6883-6901. PubMed ID: 22837670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
    Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.